Miracor Medical Systems is a medical device company developing disruptive solutions to treat severe heart diseases. The Company develops and commercializes the pressure-controlled intermittent coronary sinus occlusion impulse system, a technology platform designed to improve clinical outcome of patients with impaired cardiac function. PiCSO therapy seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after an acute myocardial infarction.